Overview
Drug safety, also termed pharmacovigilance, is the science and set of activities concerned with the detection, assessment, understanding, and prevention of adverse effects and other drug-related problems across the lifecycle of a pharmaceutical product. It spans preclinical toxicology, controlled clinical trials, and post-marketing surveillance, with the goal of characterising a medicine's benefit-risk balance under real conditions of use. Core mechanisms include systematic toxicity evaluation, in vitro disease and cardiotoxicity models that flag organ-level liability before human exposure, computational and systems-biology approaches that predict hazard, and structured reporting of adverse drug events. A persistent methodological challenge is the standardisation, codification, and accurate definition of adverse drug events, since inconsistent documentation and mapping weaken signal detection across health systems. Related sub-areas covered in this literature include preclinical screening of candidate compounds, immunological strategies for developing safer therapeutic agents, the safety implications of self-medication and improper drug storage in community settings, and the rationale for rigorous clinical testing of new drugs, treatments, and devices before market authorisation. Together these strands frame drug safety as an evidence-driven discipline integrating laboratory, clinical, and epidemiological methods to protect patients and improve therapeutic outcomes.
Research published in this journal
10 peer-reviewed articles, ranked by relevance. Each links to its DOI.
A Role for in Vitro Disease Models in the Landscape of Preclinical Cardiotoxicity and Safety Testing
Measuring Quality Change in the Market for Anti-Ulcer Drugs
The Application of Immunoglobulins Immune Response in the Discovery and Development of Safe Therapeutic Agents: A Review Article
Computational Systemic Biology for Toxicity Studies: A Mini Review of Previously Published Articles
Calcium Transient Assays for Compound Screening with Human iPSC-derived Cardiomyocytes: Evaluating New Tools
Why New Drugs, Treatments, and Medical Devices Still Needs to be Tested Clinically Before Making it Available in the Market?
Assessment of Self Medication Practice and Drugs Storage Among South Sudanese Community in Addis Ababa, Ethiopia
Investigation on the Impact of Biofield Energy Treatment on the Physical, Thermal and Spectroscopic Characteristics of Zinc Chloride
How this research is being cited
The 10 articles above have been cited 42 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
Factors influencing irresponsible self-medication in rural Ethiopia: Insights from Gimbichu district2025 · Journal of Public Health in Africa
-
2025 · Journal of Biomolecular Structure and Dynamics
-
2025 · Elsevier eBooks
-
Taylor Anglen et al. · 2025 · bioRxiv
-
2024 · RSC Advances
-
2024 · Cell stem cell
-
YI Wibowo et al. · 2024 · International Journal of Public Health Science (IJPHS)
-
Lara G. Dresser et al. · 2024 · bioRxiv
A sample of recent works citing this journal's research on Drug Safety, linking to each citing work.